RETRACTED ARTICLE: Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma

Carolina Cubillos-ZapataTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain;

Raúl CórdobaLymphoma Unit, Oncohealth Institute and Health Research Institute IIS-FJS-Autonomous University of Madrid, Madrid, Spain; ;START Madrid FJD, Phase 1 Clinical Trials Unit, Foundation Jiménez Díaz University Hospital, Madrid, Spain

Jose Avendaño-OrtizTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain;

Eduardo Lopez-CollazoTumor Immunology Laboratory, IdiPAZ, Madrid, Spain; ;Innate Immune Response Group, IdiPAZ, La Paz University Hospital, Madrid, Spain; ;Center for Biomedical Research Network, CIBEres, Madrid, Spain; Correspondence[email protected]

RETRACTED ARTICLE: Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma

ICMJE Form for Disclosure of Potential Conflicts of Interest

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

RETRACTED ARTICLE: Thalidomide analog CC-122 induces a refractory state in monocytes from patients with diffuse large B cell lymphoma

ICMJE Form for Disclosure of Potential Conflicts of Interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date